首页> 美国卫生研究院文献>Environmental Health Perspectives >Use of monoclonal and polyclonal antibodies against DNA adducts for the detection of DNA lesions in isolated DNA and in single cells.
【2h】

Use of monoclonal and polyclonal antibodies against DNA adducts for the detection of DNA lesions in isolated DNA and in single cells.

机译:抗DNA加合物的单克隆和多克隆抗体用于检测分离的DNA和单个细胞中的DNA损伤的用途。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Interaction of genotoxic chemicals with their intracellular target, i.e., DNA, may result in the formation of covalent adducts. Various methods have been developed to estimate exposure to genotoxic chemicals by means of molecular dosimetry of DNA adducts. Such experiments have generally been carried out with radiolabeled genotoxicants administered in vitro to cultured cells or in vivo to laboratory animals. Biomonitoring of human exposure to genotoxic chemicals requires methods to detect very small quantities of nonradioactive DNA adducts in limited amounts of sample. Attention has been devoted to the development of immunochemical techniques in which specific DNA adducts can be detected with antibodies. The level of sensitivity achieved in these experiments renders these methods applicable for human biomonitoring. When suitable antibodies are available, the immunochemical approach enables one to analyze various types of adducts separately, and to discriminate between irrelevant (e.g., quickly repairable) and relevant lesions (key lesions) with respect to biological end points such as mutation induction and cancer. Polyclonal and monoclonal antibodies were used for the detection of DNA adducts in animal and human tissue. Adducts were measured in DNA from various organs of rats treated with the liver carcinogen 2-AAF. Human exposure to genotoxic agents was studied by the measurement of DNA adducts in blood cells from patients treated with the genotoxic cytostatic cisplatin. Also, the development is described of a system to detect and quantitate DNA adducts at the single-cell level by means of immunofluorescence microscopy, which allows the analysis of small samples of human tissue with preservation of cell morphology.
机译:遗传毒性化学物质与其细胞内靶标(即DNA)的相互作用可能导致共价加合物的形成。已经开发出各种方法来通过DNA加合物的分子剂量测定法来估计对遗传毒性化学品的暴露。通常用放射性标记的遗传毒性剂进行此类实验,所述放射性标记的遗传毒性剂在体外施用于培养的细胞或在体内施用于实验动物。对人类暴露于遗传毒性化学物质的生物监控,需要在有限数量的样品中检测非常少量的非放射性DNA加合物的方法。已经致力于免疫化学技术的发展,其中可以用抗体检测特定的DNA加合物。这些实验中达到的灵敏度水平使这些方法适用于人类生物监测。当可获得合适的抗体时,免疫化学方法使人们能够分别分析各种类型的加合物,并就生物学终点如突变诱导和癌症区分无关的(例如,可快速修复的)和相关的损伤(关键损伤)。多克隆抗体和单克隆抗体用于检测动物和人组织中的DNA加合物。测量了用肝致癌物2-AAF处理的大鼠各个器官的DNA中的加合物。通过测量接受遗传毒性细胞生长抑制性顺铂的患者血细胞中的DNA加合物,研究了人类对遗传毒性药物的暴露情况。此外,还描述了通过免疫荧光显微镜在单细胞水平上检测和定量DNA加合物的系统的开发,该系统可以分析人类组织的小样本并保留细胞形态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号